• SENSEX 72,480.29
    -48.78 (--0.07%)
  • BANKNIFTY 54,633.05
    373.10 (+0.69%)
  • Avalon Tech
    2,171.00 778.15(%)
  • Bharti Airtel
    1,753.30 1,745.00(%)
  • NSE
    1,761.00 1,761.00(%)
  • Molbio Diagnosti
    1,368.00 1,686.50(%)
  • Apollo Hospitals
    8,063.00 6,680.00(%)
  • Innova Captab
    1,080.00 608.25(%)
  • Hero Motors
    152.58 156.03(%)
  • Meesho
    230.55 254.65(%)
  • Azad Engineering
    3,126.00 3,126.00(%)
  • Shadowfax Technologies
    278.10 98.60(%)
  • Cupid
    312.10 312.10(%)
  • L&T Finance Ltd
    264.75 234.90(%)
  • Lenskart Solut.
    698.00 725.00(%)
  • Reliance Industries
    1,196.30 1,611.20(%)
  • SS Retail
    761.45 888.00(%)
  • Sun TV Network
    664.60 664.60(%)
  • Solar Industries
    19,820.00 22,630.05(%)
  • PB Fintech.
    1,040.00 1,040.00(%)
  • National High
    168.00 142.00(%)
  • HDFC Bank
    709.70 682.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Himalaya Nutravedics India Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 96747.0
  • ISIN : INE1OTR01013
116.80 -6 (-4.96%)
  • As on 30 Sep 2026 (EOD)

  • Today’s Low

    116.80

  • Today’s High

    121.95

  • Open

    121.95

  • Perv Close

    122.90

  • 52W Low

    116.80

  • 52W High

    123.90

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    102.86

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.69

  • Debt-Equity Ratio

    -4.96

  • AGM Date

    30-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    102.86

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    8.81

  • BV (₹)

    48.70

  • Sales( ₹ in Cr.)

    43.07

  • NP (in Cr.)

    7.39

  • NP Var(%)

    231.0

  • Div%

    0.0

  • CPS (₹)

    8.80

  • EPS (₹)

    8.40

  • Traded Value (₹ in Lakhs)

    102.86

  • 52 Week High

    123.90

  • 52 Week Low

    116.80

  • Price BSE

    117.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    102.86

  • P/C Ratio

    13.40

  • P/E Ratio

    13.90

  • Price Vs.BV

    8.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar
INCOME :            
Sales Turnover 43.07 21.00 14.43 2.05 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 43.07 21.00 14.43 2.05 - -
Other Income 0.05 0.00 0.00 0.00 - -
Stock Adjustments -0.15 0.79 0.58 1.00 - -
Total Income 42.97 21.79 15.01 3.05 - -
EXPENDITURE :            
Raw Materials 22.67 13.19 8.79 1.66 - -
Power and Fuel Cost 0.16 0.12 0.13 0.04 - -
Employee Cost 2.46 2.61 2.78 0.43 - -
Other Manufacturing Expenses 3.36 0.79 0.40 0.37 - -
Selling and Administration Expenses 6.14 2.09 1.93 0.25 - -
Miscellaneous Expenses 0.02 0.00 0.03 0.02 - -
Employee Benefit Expenses 2.46 2.61 2.78 0.43 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 34.81 18.80 14.06 2.77 - -
Operating Profit 8.16 2.99 0.94 0.28 - -
Interest 0.35 0.32 0.18 0.02 - -
Gross Profit 7.81 2.67 0.76 0.26 - -
Depreciation 0.33 0.42 0.16 0.06 - -
Profit Before Tax 7.48 2.25 0.60 0.20 - -
Current Tax 0.09 0.02 0.17 0.04 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 0.00 0.00 0.00 0.01 - -
Reported Net Profit 7.39 2.23 0.43 0.15 - -
Extraordinary Items 0.00 0.00 0.00 0.00 - -
Adjusted Net Profit 7.39 2.23 0.43 0.15 - -
Adjustment below Net Profit -0.07 0.00 0.00 0.00 - -
P & L Balance brought forward 2.76 0.53 0.10 0.00 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 10.07 2.76 0.53 0.15 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 11.72 5.58 5.13 1.81 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 25.97 16.89 16.33 11.81 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    68.13%

  • Public Share Holding

    31.87%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,000,000 68.13 6,000,000 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,000,000 68.13 6,000,000 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 663,600 7.54 663,600 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 663,600 7.54 663,600 2
2] Non Institution
Bodies Corporate 670,104 7.61 670,104 6
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 12,000 0.14 12,000 5
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 167,512 1.90 167,512 53
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 85,986 0.98 85,986 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,207,118 13.71 1,207,118 399
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,142,720 24.33 2,142,720 466
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,806,320 100.00 8,806,320 474

Company Background

Himalaya Nutravedics India LtdPharmaceuticals - Indian - Formulations

  • Himalaya Nutravedics India Ltd
  • BSE Code : 96747.0
  • ISIN : INE1OTR01013

  • Incorporation Year

    2022

  • Registered Office

    No.101/A Phase 3 Indu.Dev.Park
    Cherlapally Hindustan Cables L, Hyderabad,
    Telangana-500051

  • Telephone

    +91 90634 98493

  • FAX

  • Chairman

    Rohit Asawa

  • Managing Director

  • Company Secretary

    Pooja Biyani

  • Auditor

    J Singh & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Technologies Ltd
    301 The Centrium,
    3rd Flr 57 LBS,Nav Pada Kurla(W)
    Mumbai - Mumbai-400 070

Himalaya Nutravedics India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Himalaya Nutravedics 116.80 43.12 43.07 0.00 51.73
Abbott India 27,149.40 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,188.75 2,304.07 2,275.58 91.21 27.86
Glaxosmi. Pharma 2,767.60 3,932.76 3,790.20 44.21 58.17
Novartis India 1,923.85 393.10 354.33 48.58 15.94
Cipla 1,350.00 20,102.60 18,979.95 35.48 13.88
Bliss GVS Pharma 695.35 773.53 729.81 64.62 12.51
Fermenta Biotec. 549.65 474.15 450.25 25.66 18.77
Amrutanjan Healt 514.30 520.13 502.55 27.55 24.16
Guj. Themis Bio. 387.75 168.25 165.82 103.68 18.05
Ambalal Sarabhai 39.51 19.52 3.94 73.17 6.77